Sort by
Keyphrases
Europe
100%
Antimicrobial Resistance
100%
Escherichia Coli
100%
Abdominal
100%
Klebsiella Pneumoniae (K. pneumoniae)
100%
Extended-spectrum β-lactamase
100%
Gram-negative Bacilli
100%
Antimicrobial Susceptibility
100%
Resistance Trends
100%
European Countries
50%
Antimicrobial
50%
Intra-abdominal Infection
50%
Active Agent
50%
Pseudomonas Aeruginosa (P. aeruginosa)
50%
Imipenem
50%
Reduced Susceptibility
50%
Carbapenems
50%
Amikacin
50%
Ertapenem
50%
Proteus Mirabilis
50%
Isolated Species
50%
Multidrug-resistant Isolates
50%
Klebsiella Oxytoca
50%
Hospital Center
50%
European Committee on Antimicrobial Susceptibility Testing (EUCAST)
50%
Clinical Breakpoints
50%
Positive Drug
50%
Medicine and Dentistry
Antibiotic Resistance
100%
Gram-Negative Bacteria
100%
Antibiogram
100%
Extended Spectrum Beta Lactamase
100%
Escherichia coli
66%
Antiinfective Agent
33%
Abdominal Infection
33%
Pseudomonas aeruginosa
33%
Amikacin
33%
Carbapenem Derivative
33%
Imipenem
33%
Ertapenem
33%
Klebsiella pneumoniae
33%
Proteus mirabilis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
100%
Extended Spectrum Beta Lactamase
100%
Antimicrobial Resistance
100%
Gram Negative Bacterium
100%
Escherichia coli
66%
Abdominal Infection
33%
Klebsiella pneumoniae
33%
Imipenem
33%
Amikacin
33%
Pseudomonas aeruginosa
33%
Ertapenem
33%
Carbapenem Derivative
33%
Proteus mirabilis
33%
Immunology and Microbiology
Escherichia coli
100%
Gram-Negative Bacteria
100%
Antibiotic Sensitivity
100%
Antimicrobial Resistance
100%
Klebsiella pneumoniae
50%
Pseudomonas aeruginosa
50%
Proteus mirabilis
50%